| 1 |
Lorincz AT. Reid R, Jensen AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk association of 5 common anogenital types. Obstet Gynecol 1992;79:328-37
|
| 2 |
Munger K, Phelps WC, Bobb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989;63:4417-21
PUBMED
|
| 3 |
Hopfl R, Heim K, Christensen N, et al. Spontaneous regression of CIN and delayed hypersensitivity to HPV-16 oncoprotein E7. Lancet 2000;356:1985-6
DOI
ScienceOn
|
| 4 |
Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 2000;275:6764-9
DOI
ScienceOn
|
| 5 |
Papanicolaou GN. A survey of the actualities and poten-tialities of exfoliative cytology in cancer diagnosis. Ann Med 1968;30:661-74
|
| 6 |
Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968;10:748-84
DOI
PUBMED
ScienceOn
|
| 7 |
The ASCUS-LSIL Triage Study (ALTS) Group. A randomiz-ed rial on the management of low-grade squamous intra-epithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400
DOI
|
| 8 |
McQuarrie HG, Ogden J, Costa M. Understanding the financial impact of covering new screening technology: the case of automatic Pap smears. J Reprod Med 2000;45:898-906
PUBMED
|
| 9 |
Richart RM, Wright TC Jr. Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer 1993;71: 1413-21
DOI
PUBMED
ScienceOn
|
| 10 |
Doeberitz MK. New molecular tools for efficient screening of cervical cancer. Dis Markers 2001;17:123-8
DOI
|
| 11 |
Solomon D, Davey D, Kurman RJ, et al. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9
DOI
ScienceOn
|
| 12 |
Raab SS. Human papillomavirus reporting; impact on Bethesda cytology report. Arch Pathol Lab Med 2003; 127:969-72
PUBMED
|
| 13 |
Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelia1 and invasive neoplasm. J Viral 1991;65: 606-12
|
| 14 |
Nobbenhuis M, Walboomers JMM, Helmerhorst TJM, et al. Relation of human papillomavirus to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 1999;354:20-5
DOI
ScienceOn
|
| 15 |
Mandelblatt JS, Lawrence WF, Womak SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002;287:2372-81
DOI
ScienceOn
|
| 16 |
Kim CJ, Jeong JK, Park MS, et al. HPV oligonucleotide microarray-based detection of HPV geno types in cervical neoplastic lesions. Gynecol Oncol 2003;89:21-7
|
| 17 |
Hudson JB, Bedell M, McCance DJ, Laimins LA. Immor-talization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Viral 1990;64:519-26
|
| 18 |
Reagan JW, Seidemann IL, Saracusa Y. The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix. Cancer 1953;6:224-35
DOI
ScienceOn
|
| 19 |
Cuzick J, Beverley E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer 1999;81 :554-8
DOI
ScienceOn
|
| 20 |
Ho GYF, Bjrk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71
DOI
ScienceOn
|
| 21 |
Schiffman MH, Herrero R, Hildesheim A, et al. HPV testing in cervical cancer screening; results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93
DOI
ScienceOn
|
| 22 |
Wallin KL, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1993;341: 1633-38
|
| 23 |
American Society of Cytopathology. Cervical cancer cyto-logy practice guidelines. Acta Cytol 2001;45:201-26
DOI
ScienceOn
|
| 24 |
Schiffman MH, Bauer HM, Glass AG, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64
DOI
ScienceOn
|
| 25 |
Brinton LA. Epidemiology of cervical cancer overview. The epidemiology of human papillomavirus and cervical cancer. eds. Munoz N, Bosch FX, Shah KV, Meheus A. IARC Scientific Pulblications. Lyon, 1992
|
| 26 |
Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, ASCCP-sponsored Consensus Conference. 2001 Con-sensus guidelines for the management of wornen with cervical cytological abnormalities. JAMA 2002;287:2120-9
DOI
ScienceOn
|
| 27 |
The National Cancer Institute Workshop. The Bethesda system for reporting cervical/vaginal cytology diagnoses. Acta Cytol 1993;37:115-24
|
| 28 |
Kurman RJ, Henson DE, Herbst A, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271: 1866-9
DOI
PUBMED
|
| 29 |
National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnosis. JAMA 1989;262:931-4
DOI
PUBMED
ScienceOn
|
| 30 |
Arroyo M, Bagchi S, Raychaudhuri P. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol Cell Biol 1993;13:6537-46
DOI
PUBMED
|
| 31 |
Pisani P, B:ay F, Parkin DM. Estimation of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:72-81
DOI
ScienceOn
|
| 32 |
Walker J, Bloss JD, Liao SY, Berman M, Bergen S, Wilczynski SP. Human papillomavirus genotypes as a prognostic indicator in carcinoma of uterine cervix. Obstet Gynecol 1989;74:781-5
PUBMED
|
| 33 |
Galvin GA, Jones HW, TeLinde RW. Clinical relationship of carcinoma in situ and invasive carcinoma of the uterine cervix. J Am Med Assos 1952;149:744-8
DOI
|
| 34 |
Committee for Histological Definitions. Editorial. Acta Cytol 1962;6:235-7
|
| 35 |
Cullen TS. Cancer of the Uterus, London, Kimpton. 1900
|
| 36 |
Solomon D. Role of triage testing in cervical cancer screening. J Natl Cancer Inst Monogr 2003;31:97-101
PUBMED
|
| 37 |
Bosch FX, Manos MM， Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802
DOI
ScienceOn
|
| 38 |
Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16 INK4a as specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84
DOI
ScienceOn
|
| 39 |
Bolick D, Hellman DJ. Laboratory implementation and efficacy assessment of ThinPrep cervical cancer screening system. Acta Cytol 1998;42:209-13
DOI
PUBMED
ScienceOn
|
| 40 |
Remmink AJ, Walboomers JMM, Helmerhorst TJM, et a1. The presenee of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61:306-1 1
DOI
ScienceOn
|
| 41 |
Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505
DOI
ScienceOn
|
| 42 |
zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature 2002;2:342-50
|
| 43 |
Park JS, Kim EJ, Lee JY, Sin HS, Namkoong SE, Um SJ. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int J Cancer 2001;91:822-7
DOI
ScienceOn
|
| 44 |
The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology inter-pretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-92
DOI
|
| 45 |
Solomon D, Schiffman M, Tarone R. ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9
|
| 46 |
Shlay JC, Dunn T, Byers T, Baron AE, Douglas JM Jr. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears. Obstet Gynecol 2000;96:410-6
DOI
ScienceOn
|
| 47 |
De Villiers EM. Heterogeneity of the human papillomavirus group. J Virol 1989;63:4898-903
PUBMED
|
webmaster
